XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net income $ 19,714,496 $ 9,863,660
Adjustments to reconcile net income to net cash provided by operating activities:    
Accretion of commercial mortgage loans held-for-investment discounts (1,070,701) (125,098)
Amortization of commercial mortgage loans held-for-investment premiums 19,253 61,144
Accretion of deferred loan fees (292,073) (27,084)
Amortization of deferred offering costs (56,940) (114,571)
Amortization of deferred financing costs 3,258,892 2,772,870
Provision for credit losses 2,524,216 4,258,668
Unrealized loss/(gain) loss on mortgage servicing rights 103,684 (243,659)
Restricted stock compensation expense 6,194 15,980
Net change in:    
Accrued interest receivable (2,790,814) (1,820,239)
Other assets (137,272) (226,749)
Accrued interest payable 1,731,892 1,656,754
Fees and expenses payable to Manager (18,458) (218,809)
Other accounts payable and accrued expenses 1,745,972 436,187
Net cash provided by operating activities 24,738,341 16,289,054
Cash flows from investing activities:    
Purchase and origination of commercial mortgage loans held-for-investment (594,201,680) (345,921,827)
Principal payments from commercial mortgage loans held-for-investment 277,481,511 293,326,723
Deferred loan fees 0 763,250
Net cash (used in) investing activities (316,720,169) (51,831,854)
Cash flows from financing activities:    
Proceeds from issuance of common stock 39,896 81,136,045
Dividends paid on common stock (13,057,788) (11,646,557)
Dividends paid on preferred stock (4,740,000) (4,740,000)
Proceeds from collateralized obligations 317,700,000 0
Payment of deferred financing costs (3,809,453) (119,375)
Net cash provided by financing activities 296,132,655 64,630,113
Net increase (decrease) in cash, cash equivalents and restricted cash 4,150,827 29,087,313
Cash, cash equivalents and restricted cash, beginning of period 47,366,365 18,279,052
Cash, cash equivalents and restricted cash, end of period 51,517,192 47,366,365
Supplemental disclosure of cash flow information    
Cash paid for interest 69,810,218 28,380,571
Non-cash investing and financing activities information    
Dividends declared but not paid at end of period $ 4,654,904 $ 4,315,119